Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
139
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

596
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
596
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

518
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
518
Dissociative Amnesia01:21

Dissociative Amnesia

143
Dissociative amnesia is a complex psychological condition that manifests as an inability to recall personal information, often tied to traumatic or stressful events. Unlike general amnesia, individuals with this condition retain the ability to perform routine activities and procedural tasks, such as operating a phone or navigating public transportation, yet experience profound gaps in autobiographical memory. These lapses may encompass significant life events, such as suicide attempts or...
143
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

474
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the...
474
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

297
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
297

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generation of high-expressing transposon-based stable pools to produce (1 + 1) and (2 + 1) bispecific common light chain antibodies.

Biotechnology progress·2026
Same author

Mastectomy in transgender patients: The experience of a Portuguese reference center.

JPRAS open·2026
Same author

Characterization of Antidepressant Consumption in a Portuguese Inland Population.

Healthcare (Basel, Switzerland)·2025
Same author

Chromatographic determination of antidepressants in plasma and saliva: Towards non-invasive therapeutic monitoring.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2025
Same author

Efficacy assessment of the new MWHI blue light technology against relevant healthcare-associated microbial pathogens.

Journal of applied microbiology·2025
Same author

Preliminary vegetation-based evaluation of semi-volatile organic compounds (SVOCs) using pine species: Towards pollution data comparability.

Environmental pollution (Barking, Essex : 1987)·2025

Related Experiment Video

Updated: Jul 18, 2025

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

13.7K

What do we know about pseudodementia?

Salomé Mouta1, Isabel Fonseca Vaz1, Miguel Pires1

  • 1Departamento de Psiquiatria e Saúde Mental, Unidade Local de Saude da Guarda EPE, Guarda, Portugal.

General Psychiatry
|August 25, 2023
PubMed
Summary
This summary is machine-generated.

Differentiating depression and dementia is challenging, as pseudodementia mimics cognitive decline from neurological causes. Recognizing pseudodementia, often linked to depression, is crucial for accurate diagnosis and effective treatment.

Keywords:
cognitiondepression

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.9K

Related Experiment Videos

Last Updated: Jul 18, 2025

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

13.7K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.2K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

7.9K

Area of Science:

  • Geriatric Psychiatry
  • Cognitive Neurology

Background:

  • Depression and dementia can cause similar cognitive and memory impairments.
  • Differentiating these conditions is clinically important yet challenging.
  • Pseudodementia describes dementia-like symptoms stemming from functional psychiatric conditions, most commonly depression.

Purpose of the Study:

  • To highlight the clinical significance of pseudodementia.
  • To discuss the challenges in differentiating pseudodementia from dementia.
  • To emphasize the importance of recognizing pseudodementia for appropriate management.

Main Methods:

  • Clinical description of pseudodementia.
  • Comparison of pseudodementia symptoms with dementia.
  • Identification of risk factors and affected populations.

Main Results:

  • Pseudodementia presents with cognitive deficits mimicking dementia but originates from functional psychiatric causes.
  • It is more prevalent in older adults (over 50-60 years) and shares risk factors with depression.
  • Key affected cognitive domains include memory, executive function, and speech.

Conclusions:

  • Pseudodementia can be mistaken for dementia due to overlapping symptoms.
  • Accurate identification of pseudodementia is essential for effective treatment.
  • Recognizing characteristic features aids in distinguishing it from neurodegenerative dementia.